GSC
INSY

Ground Swell Capital’s Insys Therapeutics, Inc. INSY Stock Holding History

Ground Swell Capital’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$14K Sell
732
-1,310
-64% -$20.6K 0.03% 749
2014
Q2 		$32K Buy
+2,042
New +$33K 0.06% 264

Other funds holding INSY

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BTP
Bloom Tree Partners New York $215M AUM 17.45% 1-Year Est. Return

Ground Swell Capital's INSY Position: Q3 2014 in Review

Ground Swell Capital reduced its Insys Therapeutics, Inc. (INSY) stake by 64% in Q3 2014, selling an estimated $20.6K and leaving 732 shares worth $14K. The position accounts for 0.03% of the portfolio, ranked #749.

Ground Swell Capital first reported a position in INSY in Q2 2014 and has held it in 2 quarters since. The position peaked at $32K in Q2 2014. 111 funds tracked by Wall St. Rank hold INSY as of Q3 2014.

  • Ground Swell Capital held 732 shares of Insys Therapeutics, Inc. worth $14K as of Q3 2014.
  • Ground Swell Capital sold 1,310 Insys Therapeutics, Inc. shares in Q3 2014, an estimated $20.6K.
  • Insys Therapeutics, Inc. made up 0.03% of Ground Swell Capital's portfolio in Q3 2014, its #749 holding.
  • Ground Swell Capital first reported a position in Insys Therapeutics, Inc. in Q2 2014 and has held it in 2 quarters since.
  • Ground Swell Capital's Insys Therapeutics, Inc. position peaked at $32K in Q2 2014.
  • 111 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.